Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Genscript Biotech (GNNSF) vs. Competitors

23 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GNNSFGenscript Biotech$3.88$8.58B-13.1869.14%Strong BuyUnlock the GNNSF analyst price target with TipRanks PremiumGNNSFUnlock the GNNSF top-analyst price target with TipRanks Premium
HK:2269Wuxi Biologics (Cayman)HKD 44.64HKD 190.63B33.3739.94%Strong BuyUnlock the HK:2269 analyst price target with TipRanks PremiumGNNSF vs HK:2269Unlock the HK:2269 top-analyst price target with TipRanks Premium
HK:3759Pharmaron Beijing Co., Ltd. Class HHKD 26.88HKD 78.72B40.8221.85%Strong BuyUnlock the HK:3759 analyst price target with TipRanks PremiumGNNSF vs HK:3759Unlock the HK:3759 top-analyst price target with TipRanks Premium
HK:1521Frontage Holdings Corp.HKD 2.09HKD 4.25B51.1198.57%―Unlock the HK:1521 analyst price target with TipRanks PremiumGNNSF vs HK:1521Unlock the HK:1521 top-analyst price target with TipRanks Premium
HK:1873Viva Biotech HoldingsHKD 1.17HKD 2.43B12.11-40.00%―Unlock the HK:1873 analyst price target with TipRanks PremiumGNNSF vs HK:1873Unlock the HK:1873 top-analyst price target with TipRanks Premium
HK:6821Asymchem Laboratories (Tianjin) Co., Ltd. Class HHKD 109.40HKD 57.41B42.7937.87%Strong BuyUnlock the HK:6821 analyst price target with TipRanks PremiumGNNSF vs HK:6821Unlock the HK:6821 top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GNNSFGenscript Biotech3.881.5869.14%
HK:2269Wuxi Biologics (Cayman)44.6412.4438.63%
HK:3759Pharmaron Beijing Co., Ltd. Class H26.885.3024.58%
HK:1521Frontage Holdings Corp.2.080.9991.28%
HK:1873Viva Biotech Holdings1.17-0.80-40.61%
HK:6821Asymchem Laboratories (Tianjin) Co., Ltd. Class H109.4032.4742.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts